Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective: To examine the association between serum matrix metalloproteinases-9 (MMP-9) levels and prognosis of acute ischemic stroke. Methods: We measured serum MMP-9 levels in 3,186 participants (2,008 men and 1,178 women) from the China Antihypertensive Trial in Acute Ischemic Stroke (CATIS). Study outcome data on death, major disability (modified Rankin Scale score ≥3), and vascular disease were collected at 3 months after stroke onset. Results: During 3 months of follow-up, 767 participants (24.6%) experienced major disability or died. Serum MMP-9 was significantly associated with an increased risk of death and major disability after adjustment for age, sex, time from onset to randomization, current smoking, alcohol drinking, admission NIH Stroke Scale score, diastolic blood pressure, plasma glucose, white blood cell counts, use of antihypertensive medications, and history of hypertension, coronary heart disease, and diabetes mellitus. For example, 1-SD (0.32 ng/mL) higher log–MMP-9 was associated with an odds ratio (95% confidence interval) of 1.16 (1.06–1.28) for the combined outcome of death and major disability, 1.12 (1.01–1.23) for major disability, and 1.29 (1.01–1.66) for death. The addition of serum MMP-9 to conventional risk factors improved risk prediction of the combined outcome of death or major disability (net reclassification index 9.1%, p = 0.033; integrated discrimination improvement 0.4%, p = 0.004). Conclusions: Higher serum MMP-9 levels in the acute phase of ischemic stroke were associated with increased risk of mortality and major disability, suggesting that serum MMP-9 could be an important prognostic factor for ischemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 1×
“In addition, C statistics, net reclassification index, and integrated discrimination improvement were used to evaluate the incremental prognostic value of serum MMP-9 levels beyond conventional risk factors.(20,21) All p values were 2 tailed, and a significance level of 0.”
MethodAsahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004 · cited 2×
“Moreover, experimental studies suggest that oxidative stress is also implicated in the activation of MMP-9 and blood-brain barrier injury, potentially causing adverse outcome.(6,28) Furthermore, in human studies, circulating MMP-9 has been found to be correlated with stroke severity and infarct volume, as well as bein…”
BackgroundSelf-citationMatrix metalloproteinases (MMPs) in health and disease: an overview
Malemud, C. (2006) · Frontiers in Bioscience · doi:10.2741/1915 · Cited by 705
Cited by
Wlodarczyk, L., Szelenberger, R., Cichon, N., Saluk-Bijak, J., Bijak, M., & Miller, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083949 · Cited by 51
Dickerson, F., Vaidya, D., Liu, Y., & Yolken, R. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2023.02.007 · Cited by 18
“Elevated blood levels of MMP-9 have also been associated with poorer outcome following ischemic stroke (55) and traumatic brain injury (56).”
BackgroundSudarkina, O. Y., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Remizova, J. A., Dmitrieva, V. G., Gubsky, L. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126179 · Cited by 15
“These proteins include matrix metalloproteinase 9 (MMP-9), which is activated during inflammation and may serve as a prognostic indicator of stroke severity [18]; c-Jun N-terminal kinases (JNKs), the activation of which is involved in inflammation and apoptosis [19]; the transcriptional factor c-Fos, which plays a sig…”
Background
Metadata
- Authors
- Zhong, C., Yang, J., Xu, T., Xu, T., Peng, Y., Wang, A., Wang, J., Peng, H., Li, Q., Ju, Z., Geng, D., Zhang, Y., He, J., For the CATIS Investigators, CATIS Investigators, He, J., Zhang, Y., Xu, T., Wang, D., Peng, Y., Wang, J., Ju, Z., Li, Q., Geng, D., Zhang, J., Li, D., Zhang, F., Guo, L., Sun, Y., Wang, X., Cui, Y., Li, Y., Ma, D., Zhang, D., Yang, G., Gao, Y., Zhao, L., Yuan, X., Han, X., Zhang, M., Duan, S., Feng, T., Li, J., Liu, S., Hu, W., Nie, C., & Zhao, N.
- Venue
- Neurology
- Published
- 2017-08-22
- Volume
- 89
- Issue
- 8
- Pages
- 805-812
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2738997953
- Cited by
- 164
- References
- 3
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. https://app.cochat.ai/papers/10.1212/wnl.0000000000004257
- The paper
- Zhong, C., Yang, J., Xu, T., Xu, T., Peng, Y., Wang, A., Wang, J., Peng, H., Li, Q., Ju, Z., Geng, D., Zhang, Y., He, J., For the CATIS Investigators, CATIS Investigators, He, J., Zhang, Y., Xu, T., Wang, D., . . . Zhao, N. (2017). Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology. https://doi.org/10.1212/wnl.0000000000004257
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.